Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 432 across all filing types
Latest filing 2023-02-22 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the loss of a share certificate and the consequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share transfer restrictions due to lost certificates. The content is a regulatory notification about share certificate status and does not contain financial data, management discussion, or report publication. It is not an annual report, earnings release, or any financial report. It is also not a director's dealing or capital change announcement. The document is a regulatory filing informing the exchange of a compliance matter related to share certificates. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is a direct notification, not a report or announcement of a report publication.
2023-02-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the schedule of Investors / Analysts meetings. It is a regulatory announcement about upcoming meetings and does not contain financial statements, detailed financial data, or report content. The document is short (2369 characters) and serves as an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-21 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of a share certificate and the stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The document is short (2395 characters) and serves as an official notification to the exchanges rather than a financial report or detailed filing. It does not contain financial data, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance announcements and notifications that do not fit other specific categories.
2023-02-18 English
Updates
Regulatory Filings
2023-02-13 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of those shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and duplicate issuance. The content is about notifying the exchanges of a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a report on board changes or capital structure. The document is a regulatory compliance notification about share certificate status, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance-related announcement.
2023-02-09 English
Copy of Newspaper Publication
Regulatory Filings
2023-02-04 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.